TVRD Insider Transactions — Page 3
252 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–252; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Slagel Dean | Director | 2016-01-05 | Sale | 31,224.0 | $17.01 |
| Slagel Dean | Director | 2016-01-05 | Sale | 31,224.0 | $17.01 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 2016-01-04 | Sale | 6,000.0 | $16.8 |
| Slagel Dean | Director | 2015-12-31 | Sale | 12,776.0 | $17.0 |
| Slagel Dean | Director | 2015-12-31 | Sale | 12,776.0 | $17.0 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 2015-12-01 | Sale | 6,000.0 | $16.21 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 2015-11-02 | Sale | 6,000.0 | $14.26 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 2015-10-01 | Sale | 1,500.0 | $14.44 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 2015-10-01 | Sale | 4,500.0 | $13.79 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 2015-09-01 | Sale | 7,000.0 | $18.63 |
| Schoell Josef | Chief Financial Officer | 2015-08-18 | Purchase | 3,000.0 | $22.1 |
| Stauffer Joseph William | Chief Medical Officer | 2015-08-04 | Purchase | 2,000.0 | $18.6 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 2015-08-03 | Sale | 7,000.0 | $21.41 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | 2015-07-01 | Sale | 7,000.0 | $12.22 |
| Lewis Michael E | Chief Scientific Advisor | 2015-07-01 | Sale | 7,262.0 | $11.66 |
| Lewis Michael E | Chief Scientific Advisor | 2015-06-01 | Sale | 7,262.0 | $9.5 |
| Slagel Dean | Director | 2015-05-19 | Sale | 32,266.0 | $10.0 |
| Slagel Dean | Director | 2015-05-18 | Sale | 82,945.0 | $10.04 |
| Slagel Dean | Director | 2015-05-15 | Sale | 73,600.0 | $10.0 |
| Lewis Michael E | Chief Scientific Advisor | 2015-05-01 | Sale | 7,262.0 | $10.64 |
| Lewis Michael E | Chief Scientific Advisor | 2015-04-01 | Sale | 7,262.0 | $9.9 |
| Lewis Michael E | Chief Scientific Advisor | 2015-03-02 | Sale | 7,262.0 | $10.11 |
| Schoell Josef | Chief Financial Officer | 2015-02-17 | Sale | 15,000.0 | $10.96 |
| Lewis Michael E | Chief Scientific Advisor | 2015-02-02 | Sale | 7,262.0 | $10.6 |
| VOGELBAUM MARTIN | Director | 2014-02-05 | Purchase | 225,818.0 | $11.0 |
| RUCH JOSHUA | TenPercentOwner | 2014-02-05 | Purchase | 225,818.0 | $11.0 |
| KAIROUZ HABIB | TenPercentOwner | 2014-02-05 | Purchase | 225,818.0 | $11.0 |
| LESCHLY MARK | TenPercentOwner | 2014-02-05 | Purchase | 225,818.0 | $11.0 |
| Rho Capital Partners LLC | TenPercentOwner | 2014-02-05 | Purchase | 225,818.0 | $11.0 |
| RHO Ventures VI LP | TenPercentOwner | 2014-02-05 | Purchase | 225,818.0 | $11.0 |
| RMV VI, L.L.C. | TenPercentOwner | 2014-02-05 | Purchase | 225,818.0 | $11.0 |
| CHAMPSI FARAH | TenPercentOwner | 2014-02-05 | Purchase | 2,547.0 | $11.0 |
| PENHOET EDWARD | TenPercentOwner | 2014-02-05 | Purchase | 2,547.0 | $11.0 |
| HURWITZ EDWARD | Director,TenPercentOwner | 2014-02-05 | Purchase | 2,547.0 | $11.0 |
| ALTA BIOPHARMA PARTNERS III LP | TenPercentOwner | 2014-02-05 | Purchase | 2,547.0 | $11.0 |
| ALTA BIOPHARMA MANAGEMENT III LLC | TenPercentOwner | 2014-02-05 | Purchase | 2,547.0 | $11.0 |
| ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC | TenPercentOwner | 2014-02-05 | Purchase | 2,547.0 | $11.0 |
| ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG | TenPercentOwner | 2014-02-05 | Purchase | 2,547.0 | $11.0 |
| CHAMPSI FARAH | TenPercentOwner | 2014-02-05 | Purchase | 6,940.0 | $11.0 |
| PENHOET EDWARD | TenPercentOwner | 2014-02-05 | Purchase | 6,940.0 | $11.0 |
| HURWITZ EDWARD | Director,TenPercentOwner | 2014-02-05 | Purchase | 6,940.0 | $11.0 |
| ALTA BIOPHARMA PARTNERS III LP | TenPercentOwner | 2014-02-05 | Purchase | 6,940.0 | $11.0 |
| ALTA BIOPHARMA MANAGEMENT III LLC | TenPercentOwner | 2014-02-05 | Purchase | 6,940.0 | $11.0 |
| ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC | TenPercentOwner | 2014-02-05 | Purchase | 6,940.0 | $11.0 |
| ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG | TenPercentOwner | 2014-02-05 | Purchase | 6,940.0 | $11.0 |
| CHAMPSI FARAH | TenPercentOwner | 2014-02-05 | Purchase | 103,330.0 | $11.0 |
| PENHOET EDWARD | TenPercentOwner | 2014-02-05 | Purchase | 103,330.0 | $11.0 |
| HURWITZ EDWARD | Director,TenPercentOwner | 2014-02-05 | Purchase | 103,330.0 | $11.0 |
| ALTA BIOPHARMA PARTNERS III LP | TenPercentOwner | 2014-02-05 | Purchase | 103,330.0 | $11.0 |
| ALTA BIOPHARMA MANAGEMENT III LLC | TenPercentOwner | 2014-02-05 | Purchase | 103,330.0 | $11.0 |
| ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC | TenPercentOwner | 2014-02-05 | Purchase | 103,330.0 | $11.0 |
| ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG | TenPercentOwner | 2014-02-05 | Purchase | 103,330.0 | $11.0 |